Angelo Baggiani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Angelo Baggiani has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Annalisa Liumbruno
Division of ENT, Department of Neuroscience, University of Pisa, Pisa, Italy
1 shared publication - Antonio Boldrini
U.O. Neonatology, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy
1 shared publication - Francesca Forli
Otolaryngology, Audiology, and Phoniatrics Unit, University of Pisa, 56127 Pisa, Italy
1 shared publication - Paolo Ghirri
Santa Chiara University Hospital
1 shared publication - Sara Lunardi
Department of Clinical and Experimental Medicine, Neonatal Intensive Care and Neonatology Unit, via Roma 55, Pisa 56126, Italy
1 shared publication - Stefano Berrettini
Department of Surgical, Medical, Molecular Pathology and Emergency Medicine, University of Pisa, 56126 Pisa, Italy
1 shared publication
Latest Publications
- Open Access
- 1 January 2011
- Published by Springer Nature in Italian Journal of Pediatrics
- Vol. 37 (1) , 16
Universal neonatal audiological screening: experience of the University Hospital of Pisa
The early identification of pre-lingual deafness is necessary to minimize the consequences of hearing impairment on the future communication skills of a baby. According to the most recent international guidelines the deafness diagnosis must occur before the age of three months and the prosthetic-rehabilitative treatment with a traditional hearing aid should start within the first six months. When a Cochlear implant becomes necessary, the treatment should start between the age of 12 months and 18 months. The only way to diagnose the problem early is the implementation of universal neonatal audiological screening programs. Transient evoked otoacoustic emissions (TEOAE) is the most adequate test because it's accurate, economic and of simple execution. Automatic auditory brainstem response (AABR) is necessary to identify patients with auditory neuropathy but it is also important to reduce the number of false-positives.The 20-30% of infant hearing impairment is represented by progressive or late-onset hearing loss (HL) so it's also necessary to establish an audiological follow up program, especially in infants at risk.
- 1 January 2011
- Published by Springer Nature in Italian Journal of Pediatrics
- Vol. 37 (1) , 16
Open AccessUniversal neonatal audiological screening: experience of the University Hospital of Pisa
The early identification of pre-lingual deafness is necessary to minimize the consequences of hearing impairment on the future communication skills of a baby. According to the most recent international guidelines the deafness diagnosis must occur before the age of three months and the prosthetic-rehabilitative treatment with a traditional hearing aid should start within the first six months. When a Cochlear implant becomes necessary, the treatment should start between the age of 12 months and 18 months. The only way to diagnose the problem early is the implementation of universal neonatal audiological screening programs. Transient evoked otoacoustic emissions (TEOAE) is the most adequate test because it's accurate, economic and of simple execution. Automatic auditory brainstem response (AABR) is necessary to identify patients with auditory neuropathy but it is also important to reduce the number of false-positives.The 20-30% of infant hearing impairment is represented by progressive or late-onset hearing loss (HL) so it's also necessary to establish an audiological follow up program, especially in infants at risk.